|
 |
| home > ebr > autumn 2003 > investor-exec relations: a biotech investor perspective |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
"Venture capitalists take control of your company"
"Management teams always fall out with their financial backers"
"Not so much 'venture' capital as 'vulture' capital"
Comments such as these often crop up in conversations within the biotech industry where technology entrepreneurs come face to face with venture capital investors. They smack of a normal situation gone wrong. But why does conflict between management teams of small biotech companies and their financial colleagues occur, apparently quite frequently? And is there such a thing as 'best practice' when applied to relations between investor directors and executive management? Executive management talent and all those in the venture capital community would do well to reflect on these questions, since both parties can almost certainly improve on the status quo.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Inaugural Conference on Pre-Filled Syringes
21-22 January 2009, Crowne Plaza Hotel - St James, London, UK
SMi present their Inaugural Conference on Pre-Filled Syringes 21st and 22nd January 2009 at the Crowne Plaza Hotel - St James, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Financial Times hosts the Global Pharmaceutical and Biotechnology Conference
13th November 2008
More info >> |
|
 |
